Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Current Diabetes Reports|November 2, 2006
Pramlintide: A new tool in diabetes managementLaura L Want, Robert E Ratner
The Diabetes Educator|March 7, 2008
Optimizing treatment success with an amylin analogueLaura L Want
Diabetes Technology & Therapeutics|May 23, 2002
Adjunctive therapy with the amylin analogue pramlintide leads to a combined improvement in glycemic and weight control in insulin-treated subjects with type 2 diabetesRobert E Ratner, Laura L Want, Mark S Fineman, et al.
Critical Care Nursing Quarterly|May 13, 2004
Overview of diabetesJoan K Bardsley, Laura L Want
Diabetes Technology & Therapeutics|June 7, 2018
Hypoglycemia: New Definitions and Regulatory ImplicationsRobert E Ratner
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 22, 2006
An update on the Diabetes Prevention ProgramRobert E Ratner,
Current Diabetes Reports|April 3, 2016
Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists Utilizing Data from the Exenatide Clinical Trial Development ProgramHui Peng, Laura L Want, Vanita R Aroda
The Medical Clinics of North America|February 2, 2011
Treatment recommendations for prediabetesRobert E Ratner, Anpalakan Sathasivam
The American Journal of Medicine|December 18, 2003
The roles of insulin resistance, hyperinsulinemia, and thiazolidinediones in cardiovascular diseaseGabriel I Uwaifo, Robert E Ratner
Expert Review of Endocrinology & Metabolism|February 16, 2019
Sitagliptin: an oral agent for glucose controlJoan K Bardsley, Robert E Ratner
Pageof 8